Ross McLeod Email
Market Access and Healthcare Affairs Lead, Australia, South Korea, ASEAN @ Boehringer Ingelheim
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Ross McLeod Location
- Singapore
Ross McLeod Work
- Market Access and Healthcare Affairs Lead, Australia, South Korea, ASEAN @ (June 2025 - Present)
- Director @ (October 2024 - June 2025)
- Head of Access Policy, Australia and New Zealand @ (April 2023 - October 2024)
- Health Impact Lead @ (September 2022 - April 2023)
- Market Access and Economics Advisory @ (July 2014 - April 2023)
- Director @ (December 2012 - April 2023)
- High Risk Human Research Ethics Commitee @ (November 2015 - March 2023)
- Proposal Review Commitee @ (June 2018 - May 2022)
- Technical Review Panel @ (November 2016 - October 2020)
- Independent Review Commitees @ (June 2012 - May 2014)
- Director, Asia, Africa and Middle East @ (September 2004 - August 2012)
Ross McLeod Education
- University of Oxford
Masters degree (Evidence Based Healthcare)
- London School of Hygiene and Tropical Medicine, U. of London
Master's degree (Infectious Diseases)
- The University of Queensland
Doctor of Philosophy (PhD) (Economic Evaluation)
Ross McLeod Summary
- Ross McLeod, based in Singapore, is currently a Market Access and Healthcare Affairs Lead, Australia, South Korea, ASEAN at Boehringer Ingelheim. Ross McLeod brings experience from previous roles at eSYS Development, AstraZeneca, Roche and Royal Australasian College of Surgeons. Ross McLeod holds a Masters degree in Evidence Based Healthcare @ University of Oxford. Ross McLeod has 1 emails on RocketReach.
Looking for a different Ross McLeod?
Find contact details for 700 million professionals.
Others Named Ross McLeod
Ross McLeod
President and CEO
Toronto, CA
Ross McLeod
Founder, Artist and Brand Manager
Amsterdam, NH, NL
Top Boehringer Ingelheim Employees
Shashank Deshpande
Chairman of the Board of Managing Directors and Head of Human Pharma
Ingelheim am Rhein, RP, DE
Alexander Haydl
Chief AI Officer (Development Human Pharma)
Ingelheim am Rhein, RP, DE
Max Schrecklinger
CFO Human Pharma Business Unit
Ingelheim am Rhein, RP, DE
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co